Treatment of non-metastatic castration-resistant prostate cancer
Benefits sustained only on surrogate endpoints
1 COMENTÁRIOSBenefits sustained only on surrogate endpoints
1 COMENTÁRIOSTherapeutic options and toxicity profile
0 COMENTÁRIOSInternational cooperative effort
0 COMENTÁRIOSConcerns about futility, obsolescence and uncertainties
0 COMENTÁRIOS